TFM
XBI icon

Trademark Financial Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Trademark Financial Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
3,120
+871
+39% +$118K 0.2% 72
2026
Q1 		$287K Buy
+2,249
New +$281K 0.14% 91

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Trademark Financial Management's XBI Position: Q2 2026 in Review

Trademark Financial Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, buying an estimated $118K and bringing the position to 3,120 shares worth $494K. The position accounts for 0.2% of the portfolio, ranked #72.

Trademark Financial Management first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 392 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Trademark Financial Management held 3,120 shares of State Street SPDR S&P Biotech ETF worth $494K as of Q2 2026.
  • Trademark Financial Management bought 871 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $118K.
  • State Street SPDR S&P Biotech ETF made up 0.2% of Trademark Financial Management's portfolio in Q2 2026, its #72 holding.
  • Trademark Financial Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 392 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Trademark Financial Management's 13F filing for Q2 2026, filed 27 Jul 2026.